Leadership teams across several Swiss companies have recently increased their purchases of firm shares following notable downward pressure on equity valuations. At private markets specialist Partners Group, whose headquarters are located in Baar, members of the board of directors and management acquired private shares totaling roughly 21 million francs across three trading sessions from October 6 to October 8. This activity brings total purchases by insiders to nearly 39 million francs since the beginning of September. The transactions follow a prolonged decline in the company's share price throughout the year, compounded by redemption requests in evergreen funds, a short-seller attack, and a scheduled CEO transition. By the third quarter, Partners Group shares continued their downward trend to trade just above 600 francs, marking a roughly 55 percent drop compared to the spring of 2025. Two factors noted by observers include a price-to-earnings ratio of 14 based on 2027 forecasts, reaching a 14-year low, and Bloomberg data showing fewer than 40 percent of analysts recommending the stock, a level not seen since 2014.
At train manufacturer Stadler Rail, company patron Peter Spuhler and other executives have maintained investments despite past volatility. Following strong first-half results that featured a 40 percent rise in revenue and a more than doubled operating profit, a member of the executive board recently acquired shares valued at nearly 1.5 million francs, a transaction reported to the SIX Swiss Exchange at the end of September. The valuation remains below the long-term average, with a price-to-earnings ratio of 16.5 compared to a historical average of 19.6. Upcoming milestones for Stadler Rail include the annual report on March 17, 2027, and the half-year report at the end of August 2027.
EFG International experienced a volatile period with an overall share price decline of roughly 18 percent for the year, influenced by lower first-half earnings driven by higher costs against largely stagnant revenues. Following management sales in previous weeks, a member of the board of directors purchased shares worth 2.1 million francs on October 1. EFG is scheduled to publish a trading update covering the past ten months on November 24, followed by full-year results on February 17, with investor focus remaining on asset growth and margins.
Orthopedics firm Medacta, based in Ticino, has posted consistent annual revenue growth of around 15 percent, though shares fell by nearly 27 percent this year and roughly 33 percent from their February peak. An unexpected slowdown in the United States market created margin pressure, reducing first-half profit from nearly 61 million francs in the prior year to just under 42 million francs. In response to the correction, which placed the price-to-earnings ratio at 22.3 based on next year's forecasts—significantly below the long-term average of nearly 34—insiders have engaged in regular purchases. Management reported transactions totaling about 2.15 million francs to the SIX exchange since mid-September, while a board member sold shares valued at over 713,000 francs during the same period.
At real estate company Warteck Invest, a member of the board of directors acquired shares valued at 1.5 million francs in mid-September, surpassing the scale of typical transactions for the small-cap firm, which generally range between 20,000 and 360,000 francs. The company's shares are down 2.3 percent for the year, exhibiting lower volatility compared to peers such as PSP and SPS.
